微侵袭血肿清除术对高血压脑出血患者术后神经功能恢复及并发症的影响

doi:10.3969/j.issn.1009-976X.2020.04.013

摘要/Abstract

摘要： 目的分析微侵袭血肿清除术对高血压脑出血患者术后神经功能恢复及并发症的影响。方法选取2017年6月至2020年5月期间我院38例高血压脑出血患者,按照手术方式不同将患者分为微侵袭组（n=12）和大骨瓣组（n=26）。微侵袭组给予微侵袭血肿清除术治疗;大骨瓣组采用基底节区改良翼点入路,骨窗大小约为6 cm×8 cm。比较两组患者临床疗效、手术情况、临床神经功能缺失量表（NDS）评分、日常生活能力量表（ADL）评分以及并发症发生情况。结果微侵袭组患者总好转率为91.67%,高于大骨瓣组的73.07%,差异无统计学意义（P>0.05）;微侵袭组手术时间、术中出血量明显小于大骨瓣组（P<0.05）,两组血肿清除率、住院时间比较无明显差异（P>0.05）;手术后3个月,两组患者NDS评分均明显低于本组手术前（P<0.05）,ADL评分均明显高于本组手术前（P<0.05）,微侵袭组患者NDS评分明显低于大骨瓣组（P<0.05）,ADL评分明显高于大骨瓣组（P<0.05）;两组患者颅内感染、肺部感染以及再出血并发症总发生率对比无统计学差异（P>0.05）。结论与传统大骨瓣开颅术相比,微侵袭血肿清除术治疗高血压脑出血更加安全有效,患者术后神经功能恢复更好,并发症更少。

关键词: 并发症, 微侵袭血肿清除术, 高血压脑出血, 神经功能

Abstract: Objective To analyze the effects of minimal invasive hematoma removal on postoperative neurological function recovery and complications in patients with hypertensive intracerebral hemorrhage. Methods From June 2017 to May 2020, 38 patients with hypertensive intracerebral hemorrhage in our hospital were selected and divided into craniotomy group （n=26） and minimal invasive group （n=12） according to different surgical methods. Minimal invasive group was given microinvasive hematoma removal, and craniotomy group was given an approximately 6 cm×8 cm bone window craniotomy. The clinical efficacy, surgical status, clinical neurological deficit scale （NDS） score and ability of daily living scale （ADL） score and the occurrence of complications were compared between the two groups. Results The total improvement rate of patients in minimal invasive group was higher than that in craniotomy group （91.67% vs. 73.07%）（P>0.05）. The operative time and intraoperative blood loss in minimal invasive group were significantly less than those in craniotomy group （P<0.05）. There was no significant difference in the hospital stay and hematoma clearance rate between the two groups （P>0.05）. At 3 months after surgery, the NDS scores in the two groups were significantly lower than those in the same group before surgery （P<0.05）, and the ADL scores were significantly higher than those in the same group before surgery （P<0.05）. The NDS score in minimal invasive group was significantly lower than that in craniotomy group （P<0.05） while the ADL score was significantly higher than that in craniotomy group （P<0.05）. The total incidence rate of complications such as intracranial infection, pulmonary infection and rebleeding between two groups had no significance （P<0.05）. Conclusion Compared with craniotomy group, minimal invasive surgery treatment is safer and more effective in treating hypertensive intracerebral hemorrhage, and it has better recovery of postoperative neurological function and fewer complications.

Key words: hypertensive intracerebral hemorrhage, complications, neurological function, minimal invasive surgery treatment

中图分类号:

R651.1

顾威庭, 赵俊文, 赵东明, 成侃, 蔡瑜. 微侵袭血肿清除术对高血压脑出血患者术后神经功能恢复及并发症的影响[J]. 岭南现代临床外科, 2020, 20(04): 463-467.

GU Wei-ting, ZHAO Jun-wen, ZHAO Dong-ming, CHENG Kan, CAI Yu. Effects of minimal invasive surgery treatment on postoperative neurological function recovery and complications in patients with hypertensive intracerebral hemorrhage[J]. Lingnan Modern Clinics in Surgery, 2020, 20(04): 463-467.

参考文献

[1] Liu M, Wu B, Wang WZ, et al.Stroke in China: epidemiology, prevention, and management strategies[J]. Lancet Neurol, 2007, 6(5): 456-464.
[2] Rincon F, Mayer SA.Intracerebral hemorrhage: getting ready for effective treatments[J]. Curr Opin Neurol, 2010, 23(1): 59-64.
[3] Yang G, Shao GF.Clinical Effect of Minimally Invasive Intracranial Hematoma Elimination on Hypertensive Intracerebral Hemorrhage[J]. Pak J Med Sci, 2016, 32(3): 677-681.
[4] Xu X, Chen X, Li F, et al.Effectiveness of endoscopic surgery for supratentorial hypertensive intracerebral hemorrhage: a comparison with craniotomy[J]. J Neurosurg, 2018, 128(2): 553-559.
[5] Tang Y, Yin F, Fu D, et al.Efficacy and safety of minimal invasive surgery treatment in hypertensive intracerebral hemorrhage: a systematic review and meta-analysis[J]. BMC Neurol, 2018, 18(1): 136.
[6] Sun GQ, Li XL, Chen XT, et al.Comparison of keyhole endoscopy and craniotomy for the treatment of patients with hypertensive cerebral hemorrhage[J]. Medicine (Baltimore), 2019, 98(2): 14123-14130.
[7] Chen QT.Evaluation criteria of clinical neurological functional impairment in patients with cerebral apoplexy[J]. Chin J Neurol, 1996, 29(6): 381-383.
[8] Sun YZ, Xu BQ, Zhang Q.Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage[J]. Pak J Med Sci, 2018, 34(1): 73-77.
[9] 冯家强, 余瑞钿, 罗江兵, 等. 近红外光谱技术在高血压脑出血术中监测运用的探讨[J]. 岭南现代临床外科, 2019, 19(5): 576-579.
[10] Qureshi AI, Palesch YY, Barsan WG, et al.Intensive blood-pressure lowering in patients with acute cerebral hemorrhage[J]. N Engl J Med, 2016, 375(11): 1033-1043.
[11] Schlunk F, Greenberg SM.The Pathophysiology of intracerebral hemorrhage formation and expansion[J]. Transl Stroke Res, 2015, 6(4): 257-263.
[12] Riveralara L, Murthy SB, Nekoovaghttak S, et al.Influence of bleeding pattern on ischemic lesions after spontaneous hypertensive intracerebral hemorrhage with intraventricular hemorrhage[J]. Neurocrit Care, 2018, 1(1): 1-9.
[13] 龙晓东, 刘之彝, 杨与敏. 超早期小骨窗微创颅内血肿清除术对高血压脑出血患者生活质量和ET、AVP水平的影响[J]. 脑与神经疾病杂志, 2019, 27(3): 169-173.
[14] Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(7): 2032-2060.
[15] Zhou X, Chen J, Li Q, et al.Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials[J]. Stroke, 2012, 43(11): 2923-2930.
[16] Chi FL, Lang TC, Sun SJ, et al.Relationship between different surgical methods, hemorrhage position, hemorrhage volume, surgical timing, and treatment outcome of hypertensive intracerebral hemorrhage[J]. World J Emerg Med, 2014, 5(3): 203-208.
[17] 李晓腾, 陈荣彬, 李一明, 等. 内镜下微侵袭手术治疗高血压脑出血的预后影响因素[J].中国微侵袭神经外科杂志, 2018, 215(4): 9-11.